Correlation Between Platinum Investment and CRISPR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Platinum Investment and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Platinum Investment and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Platinum Investment Management and CRISPR Therapeutics AG, you can compare the effects of market volatilities on Platinum Investment and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Platinum Investment with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Platinum Investment and CRISPR Therapeutics.
Diversification Opportunities for Platinum Investment and CRISPR Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Platinum and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Platinum Investment Management and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and Platinum Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Platinum Investment Management are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of Platinum Investment i.e., Platinum Investment and CRISPR Therapeutics go up and down completely randomly.
Pair Corralation between Platinum Investment and CRISPR Therapeutics
If you would invest 4,080 in CRISPR Therapeutics AG on November 7, 2024 and sell it today you would earn a total of 0.00 from holding CRISPR Therapeutics AG or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Platinum Investment Management vs. CRISPR Therapeutics AG
Performance |
| Timeline |
| Platinum Investment |
| CRISPR Therapeutics |
Platinum Investment and CRISPR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Platinum Investment and CRISPR Therapeutics
The main advantage of trading using opposite Platinum Investment and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Platinum Investment position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.| Platinum Investment vs. Blackstone Group | Platinum Investment vs. The Bank of | Platinum Investment vs. Ameriprise Financial | Platinum Investment vs. State Street |
| CRISPR Therapeutics vs. SIVERS SEMICONDUCTORS AB | CRISPR Therapeutics vs. NorAm Drilling AS | CRISPR Therapeutics vs. Volkswagen AG | CRISPR Therapeutics vs. Darden Restaurants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |